Carnitine: Clinical Trials

8 trials of Carnitine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown, 1 recruiting, 1 terminated. 8 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 18Completed 3, Unknown 2, Recruiting 1, Terminated 1, Withdrawn 1
Phase 23Completed 1, Recruiting 1, Unknown 1

Follow Carnitine: new trials by email Literature Review of Carnitine trials Research Report on Carnitine

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
PolyCore (Polydextrin, L-Carnitine, D-xylitol) - Congestive Heart Failure
Phase 1 / Phase 2RecruitingIperboreal Pharma Srl842025-04-162025-05-16
Enhancing the Effects of Alcohol Treatment With L-Carnitine
L-carnitine - Alcohol Use Disorder
Phase 1CompletedBrown University242024-09-272025-06-15
Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension
L-carnitine - Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension
Phase 1CompletedVanderbilt University Medical Center102021-09-292025-09-30
Does Clinical Treatment of Mitochondrial Dysfunction Impact Autism Spectrum Disorder (ASD)?
Mitochondrial Cocktail - Autism Spectrum Disorders, Mitochondrial Diseases
Phase 1UnknownDrexel University502016-03-012017-04-14
Sperm DNA Damage in β-thalassemia Major: Is There a Role for Antioxidants?
L-Carnitine and N-acetyl cysteine - Endocrine Disease, Fertility Decreased Male
Phase 1 / Phase 2UnknownAin Shams University302015-02-012017-01-09
Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow
IV L-carnitine - Heart Septal Defects, Ventricular, Atrioventricular Septal Defect
Phase 1WithdrawnUniversity of California, San Francisco2014-12-012020-05-06
L-Carnitine Administration in Early Sepsis
L-Carnitine, Normal Saline - Septic Shock
Phase 1TerminatedWake Forest University Health Sciences312010-09-012022-04-22
CARNIVAL Type I: Valproic Acid and Carnitine in Infants With Spinal Muscular Atrophy (SMA) Type I
Valproic Acid and Levocarnitine - Spinal Muscular Atrophy Type I
Phase 1 / Phase 2CompletedUniversity of Utah402008-04-012015-06-15

Conditions studied

Alcoholism (1)  ·  Atrioventricular Septal Defect (1)  ·  Autism Spectrum Disorder (1)  ·  Endocrine System Diseases (1)  ·  Familial Primary Pulmonary Hypertension (1)  ·  Heart Defects, Congenital (1)  ·  Heart Failure (1)  ·  Heart Septal Defects, Ventricular (1)  ·  Lung Diseases (1)  ·  Mitochondrial Diseases (1)  ·  Muscular Atrophy, Spinal (1)  ·  Pulmonary Arterial Hypertension (1)  ·  Sepsis (1)  ·  Shock (1)  ·  Shock, Septic (1)

Sponsors

Ain Shams University (1)  ·  Brown University (1)  ·  Drexel University (1)  ·  Iperboreal Pharma Srl (1)  ·  University of California, San Francisco (1)  ·  University of Utah (1)  ·  Vanderbilt University Medical Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (6)  ·  Canada (1)  ·  Egypt (1)  ·  Germany (1)  ·  Italy (1)

Top investigators

Alan E Jones, MD (1)  ·  Anna R Hemnes (1)  ·  Edoardo Gronda, MD (1)  ·  Heba H Elsedfy, Professor (1)  ·  Jeffrey Fineman, MD (1)  ·  Kathryn Swoboda, M.D. (1)  ·  Michael J Goldenthal, PhD (1)  ·  Robert Miranda, PhD (1)  ·  Sandra P Reyna, M.D. (1)

Results publications

PMID 26825368

NIH funding

R21AA029033 (1)